中西药联合人工肝治疗39例重型病毒性肝炎患者存活率分析  

Clinical Analysis of ALSS and Yingzhihuang Injection and HGF in Treatment of 39 Patients with Severe Hepatitis

作　　者：邹圣强 张园海 於学军 史正全 申悦平 王晨红 姜林仙 吴翠松 李芬芬 金跃明 

机构地区：[1]镇江市第三人民医院肝病科,江苏镇江212003

出　　处：《中西医结合肝病杂志》2004年第1期6-7,共2页Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases

基　　金：镇江市社会发展科技计划项目 (No SH2 0 0 2 0 38)

摘　　要：目的 :探讨茵栀黄注射液和促肝细胞生长素联合人工肝 (血浆置换法 )治疗重型肝炎的疗效。方法 :3 9例重型肝炎患者在内科治疗基础上 ,给予茵栀黄注射液和促肝细胞生长素联合血浆置换法治疗 71例次。结果 :经联合治疗后 ,住院存活率为 69 2 9% ( 2 7/3 9)较对照组 41 12 % ( 2 1/5 1)明显提高 (P <0 0 1)。结论 :中西药联合人工肝 (血浆置换法 )治疗可明显提高早、中期重型病毒性肝炎的住院存活率 ,是一种安全、有效的治疗方法 ,宜在内科综合治疗基础上早期施行。Objective:To study the survival rate of the patient in hospital for the therapeutic results of ALSS(PE) and Yingzhihuang injection and HGF in the treatment of severe hepatitis.Methods: 39 patient with severe hepatits were treaed 71 times by using the PE and Yingzhihuang injection and HGF on the basis of medical treatments.Results: 39 patients were relieved in clinical symptom and their liver functions were obviously improved after the treatment of PE.The general survival rate was 69.29%(27/39).Conclusion: PE and Yingzhihuang injectiopn and HGF is an effective and safe means for therapy of severe hepatitis.The therapy should be used in early stage.

关 键 词：人工肝 重型病毒性肝炎 茵栀黄注射液 促肝细胞生长素 血浆置换法 中西医结合 

分 类 号：R512.6[医药卫生—内科学]